8legs: Initial public offering

Your Followed Topics

#1 out of 2

Avalyn Pharma debuts on the U.S. stock market, signaling a strong investor reception.
Novo Holdings now owns 8% of Avalyn Pharma after the IPO.
The IPO concludes more than nine years of Novo Nordisk Holdings’ ownership of Avalyn.
Avalyn focuses on inhaled treatments for lung diseases.
Novo Nordisk Holdings is linked to Avalyn through ownership.
Access to the full article may require a subscription.

Vote 0

#2 out of 2

Futures rise as investors await the start of the trading day, following mixed tech earnings.
Powell signals continued Fed involvement after his chair term ends, reflecting ongoing scrutiny.
Oil prices jump as Brent crude hits fresh highs amid Iran-related tension and potential military-action briefing.
Meta, Amazon, Microsoft, and Alphabet reports shape AI and cloud momentum for tech stocks.
Fed holds rates steady amid dissent, marking the highest intra-dissent since 1992.
Ford posts strong results, guiding higher on tariff refunds and better earnings than a year ago.
Pershing Square IPO debuts with mixed reception as Ackman-led listing closes below IPO price.
CNBC Morning Squawk previews key stories ahead of the market open, including Musk-Altman trial notes.
Automotive sector shows resilience with Carvana gains and Ford strength amid earnings.
Investors monitor Powell’s comments and potential policy signaling for the near term.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.